| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 71.00 k | 71.00 k | 71.00 k | 71.00 k | 71.00 k | 71.00 k |
| Cash burn (monthly) | 49.33 k | 714.42 k | 1.94 mm | 1.19 mm | 666.33 k | 889.33 k |
| Cash used (since last report) | 224.29 k | 3.25 mm | 8.81 mm | 5.43 mm | 3.03 mm | 4.04 mm |
| Cash remaining | -153.29 k | -3.18 mm | -8.74 mm | -5.36 mm | -2.96 mm | -3.97 mm |
| Runway (months of cash) | -3.1 | -4.4 | -4.5 | -4.5 | -4.4 | -4.5 |
| 13F holders | Current |
|---|---|
| Total holders | 30 |
| Opened positions | 5 |
| Closed positions | 5 |
| Increased positions | 1 |
| Reduced positions | 5 |
| 13F shares | Current |
|---|---|
| Total value | 210.95 mm |
| Total shares | 65.90 mm |
| Total puts | 0.00 |
| Total calls | 34.50 k |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Corvus Capital | 30.05 mm | $93.15 mm |
| Nirland | 14.50 mm | $2.61 mm |
| AZN AstraZeneca | 9.50 mm | $1.17 mm |
| Murphy Canyon Acquisition Sponsor | 4.72 mm | $0.00 |
| Polar Asset Management Partners | 950.00 k | $15.15 mm |
| Saba Capital Management | 765.00 k | $12.20 mm |
| MMCAP International Inc. SPC | 700.00 k | $8.26 mm |
| Exos Asset Management | 554.65 k | $6.55 mm |
| Walleye Capital | 516.03 k | $6.09 mm |
| Clear Street | 409.53 k | $5.00 k |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 18 Dec 24 | Chele Chiavacci Farley | Stock Option Common Stock | Grant | Acquire A | No | No | 0.071 | 420,000 | 29.82 k | 420,000 |
| 18 Dec 24 | Lewis-Hall Freda C | Stock Option Common Stock | Grant | Acquire A | No | No | 0.071 | 420,000 | 29.82 k | 420,000 |
| 18 Dec 24 | Simon Jeremy Fry | Stock Option Common Stock | Grant | Acquire A | No | No | 0.071 | 420,000 | 29.82 k | 420,000 |
| 18 Dec 24 | Faith L. Charles | Stock Option Common Stock | Grant | Acquire A | No | No | 0.071 | 420,000 | 29.82 k | 420,000 |
